A Study Of Crizotinib Versus Chemotherapy In Previously Untreated ALK Positive East Asian Non-Small Cell Lung Cancer Patients

Clinical trial NCT01639001 · COMPLETED

Trial details

NCT number: NCT01639001
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

NSCLC (Non-small Cell Lung Cancer)

Start date: 2012-09-29
Primary completion: 2015-06-30
Enrollment: 207

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.